U.S. flag

An official website of the United States government

NM_000238.4(KCNH2):c.1001C>T (p.Pro334Leu) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jul 15, 2014
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000181776.1

Allele description

NM_000238.4(KCNH2):c.1001C>T (p.Pro334Leu)

Gene:
KCNH2:potassium voltage-gated channel subfamily H member 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q36.1
Genomic location:
Preferred name:
NM_000238.4(KCNH2):c.1001C>T (p.Pro334Leu)
Other names:
p.P334L:CCC>CTC
HGVS:
  • NC_000007.14:g.150957418G>A
  • NG_008916.1:g.25509C>T
  • NM_000238.4:c.1001C>TMANE SELECT
  • NP_000229.1:p.Pro334Leu
  • NP_000229.1:p.Pro334Leu
  • NP_742053.1:p.Pro334Leu
  • LRG_288t1:c.1001C>T
  • LRG_288t2:c.1001C>T
  • LRG_288:g.25509C>T
  • LRG_288p1:p.Pro334Leu
  • LRG_288p2:p.Pro334Leu
  • NC_000007.13:g.150654506G>A
  • NM_000238.2:c.1001C>T
  • NM_000238.3:c.1001C>T
  • NM_172056.2:c.1001C>T
Protein change:
P334L
Links:
dbSNP: rs199472888
NCBI 1000 Genomes Browser:
rs199472888
Molecular consequence:
  • NM_000238.4:c.1001C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000234079GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Pathogenic
(Jul 15, 2014)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000234079.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

p.Pro334Leu (CCC>CTC): c.1001 C>T in exon 5 of the KCNH2 gene (NM_000238.2). The P334L variant in the KCNH2 gene has been reported in association with LQTS (Lupoglazoff et al., 2001; Imboden et al., 2006). The P334L was identified as a novel mutation in 1 out of 57 affected individual with LQTS, and was absent from 150 control chromosomes (Lupoglazoff et al., 2001). Additionally, of the 240 families of European ancestry with LQTS studied by Imoboden et al., 2006, one family was reported to harbor the P334L mutation. The P334L variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense mutations in nearby residues (R328C, D342V) have been reported in association with LQTS, supporting the functional importance of this region of the protein. Furthermore, the P334L variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. In summary, P334L in the KCNH2 gene is interpreted as a disease-causing mutation. The variant is found in LQT panel(s).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 18, 2022